Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PREVENT-MINS: Ivabradine for Prevention of Myocardial Injury after Noncardiac Surgery
2020-004877-38Phase 3Active
- Sponsor
- Jagiellonian University
- Start
- Jan 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of ivabradine in Myocardial injury, cardiac ischemia and atherosclerotic disease, sponsored by Jagiellonian University. Started Jan 2021; status: active.
02
Drugs
ivabradine
03
Conditions
Myocardial injurycardiac ischemiaatherosclerotic disease
Beyond the preview
Go deeper on 2020-004877-38.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-004877-38.